- Home
- SURG vs ARTV Comparison
SURG vs ARTV Comparison
Compare SURG & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ARTV
- Stock Information
- Founded
- SURG 2006
- ARTV 2019
- Country
- SURG United States
- ARTV United States
- Employees
- SURG N/A
- ARTV N/A
- Industry
- SURG Advertising
- ARTV
- Sector
- SURG Consumer Discretionary
- ARTV
- Exchange
- SURG Nasdaq
- ARTV NYSE
- Market Cap
- SURG 56.5M
- ARTV 50.7M
- IPO Year
- SURG N/A
- ARTV 2024
- Fundamental
- Price
- SURG $2.70
- ARTV $1.63
- Analyst Decision
- SURG Strong Buy
- ARTV Strong Buy
- Analyst Count
- SURG 1
- ARTV 8
- Target Price
- SURG $9.00
- ARTV $18.14
- AVG Volume (30 Days)
- SURG 84.4K
- ARTV 155.1K
- Earning Date
- SURG 08-12-2025
- ARTV 05-08-2025
- Dividend Yield
- SURG N/A
- ARTV N/A
- EPS Growth
- SURG N/A
- ARTV N/A
- EPS
- SURG N/A
- ARTV N/A
- Revenue
- SURG $40,029,467.00
- ARTV N/A
- Revenue This Year
- SURG $124.78
- ARTV N/A
- Revenue Next Year
- SURG $49.21
- ARTV N/A
- P/E Ratio
- SURG N/A
- ARTV N/A
- Revenue Growth
- SURG N/A
- ARTV N/A
- 52 Week Low
- SURG $1.05
- ARTV $1.55
- 52 Week High
- SURG $3.52
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- SURG 47.31
- ARTV N/A
- Support Level
- SURG $2.70
- ARTV N/A
- Resistance Level
- SURG $2.95
- ARTV N/A
- Average True Range (ATR)
- SURG 0.17
- ARTV 0.00
- MACD
- SURG -0.03
- ARTV 0.00
- Stochastic Oscillator
- SURG 27.91
- ARTV 0.00
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).